TARDBP and amyotrophic lateral sclerosis: To date, this is possible only when a genetic cause is present (e.g., mutations in MAPT and Tau pathology, in GRN and C9orf72 and TDP-43 pathology) or for specific phenotypes (e.g., the ALS-FTSD spectrum is primarily associated with TDP-43 pathology).